Summer Programs of Innovation and Diversity

LEADER/PEPP Program participants and leaders sitting together at an outdoor table for lunch.
September 6, 2022
This summer, the office of Diversity, Equity, Accessibility, and Inclusion (DEAI), hosted two intensive summer research programs: Project Engage Pharmacy Program (PEPP) Camp and the Leadership Through Engagement For the Advancement of Diverse Educational Research (LEADER) Program.

Williams Talks to KXAN About How Thin Film Freezing Can Help Treat COVID Patients

A man wearing glasses.
July 30, 2021
Division Head and Professor of Molecular Pharmaceutics and Drug Delivery Dr. Bill Williams was on KXAN News to talk about promising new data from TFF Pharmaceuticals and Augmenta Bioworks. The companies plan to develop Dr. Williams' thin film freezing technology to better deliver antibody treatment directly to the lungs of COVID patients.

UT Austin Students Earn Diversity Leadership Awards

TADOHE: Texas Association of Diversity Officers in Higher Education
June 14, 2021
The University of Texas at Austin community members won several Emerging Leaders Spotlight Awards during the recent chapter meeting of the Texas Association of Diversity Officers in Higher Education (TADOHE). The inaugural awards seek to highlight and acknowledge individuals in higher education who actively support TADOHE’s mission and diversity, equity, accessibility and inclusion (DEAI) as a whole.

"I'm Sorry" Isn't Enough, Action Must Also Fortify the Spirit of Apology

March 17, 2021
A message from Assistant Dean of Diversity and Inclusion responding to the tragic recent events in Atlanta and its impact on the Asian-American and Pacific-Islander (AAPI) community.

Has a UT Professor Found a Way to Stop COVID-19 Vaccines From Spoiling?

A fruit roll treat floating in the clouds with a rainbow behind it and small viruses hovering around it.
February 24, 2021
Molecular Pharmaceutics and Drug Delivery Professor Maria A. Croyle, Ph.D. received extensive coverage in the March 2021 edition of Texas Monthly regarding her innovative peelable film drug delivery research. Among its many potential applications, Dr. Croyle’s technology could deliver COVID-19 vaccines through a small oral strip, without need for refrigeration or extensive storage and transportation infrastructure.

Croyle Earns Funding for SARS-CoV-2 Research

A woman smiling.
January 13, 2021
Molecular Pharmaceutics and Drug Delivery professor Maria A. Croyle R.Ph., Ph.D. earned 2021’s David Lehr Research Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Dr. Croyle will receive research funding to investigate novel regulatory mechanisms of drug metabolism in the context of active infection with SARS-CoV-2 and after recovery.

Williams Wants to Turn COVID-19 Vaccine into Powder to Help with Storage and Distribution

A powder in a vial.
November 25, 2020
Molecular Pharmaceutics and Drug Delivery Professor Robert O. (Bill) Williams III, Ph.D. talks to CBS Austin about the potential for his thin film freezing technology to increase the shelf life of COVID-19 vaccines when they become available.

UT College of Pharmacy Receives Insight Into Diversity HEED Award

Insight Into Diversity Health Professions Higher Education Excellence in Diversity Award 2020.
October 2, 2020
The UT College of Pharmacy received the 2020 Health Professions Higher Education Excellence in Diversity (HEED) Award from INSIGHT Into Diversity magazine, the oldest and largest diversity-focused publication in higher education.

New Thin Film Technology to Revolutionize Storage and Distribution of Biologic Treatments and Vaccines

A hand touching a transparent sheet.
September 29, 2020
The newly-formed Jurata Thin Film will work to bring Dr. Maria Croyle's thin film technology to market, allowing biologics and vaccines to be packaged, shipped, and stored at room temperature for extended periods of time.

Live Subject Testing Shows Promising Delivery Method for COVID-19 Antiviral Treatment

A microscopic image.
September 23, 2020
Live subject testing results from the Williams Lab show that dry powder inhalation could be a potent and effective delivery method of the antiviral remdesivir to treat patients affected by COVID-19.